July CPI, Disney’s Mixed Quarter, and the Weight-Loss Drug Market 8/10/23

July CPI is out this morning and is expected to show that the pace of price increases is easing. Citi Global Wealth’s Steven Wieting discusses. Plus, Disney shares are higher after the company posted a mixed quarter, where it beat on EPS but missed on revenue and subscriber estimates. Citigroup’s Jason Bazinet dives into the report. And, demand for weight-loss drugs continue to surge, with Novo Nordisk reporting a five-fold jump in sales for its WeGovy product. Barclays’ Emily Field explains.